Physician profile
Tyler Greshow
NPI 1265070866
$6,627.66
in general payments reported to CMS, 2019-2025
20 companies · $2,951 in 2025
The $2,951 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $220 · 2022: $350 · 2023: $474 · 2024: $2,632 · 2025: $2,951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,048 · Travel and Lodging: $3,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,047.70 |
| Travel and Lodging | $3,009.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $5,050.46 | 2023-2025 | Indigo System, Ruby Coil, Pod |
| Boston Scientific Corporation | $534.64 | 2022-2025 | Embold Fibered, Watchman Flx, Therasphere Y90 Glass Microspheres 10 Gbq |
| Edwards Lifesciences Corporation | $232.16 | 2022-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Inari Medical, INC. | $165.28 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $102.13 | 2022-2025 | Trek, Powerport Clearvue Isp Implantable Port |
| Ucb, INC. | $81.52 | 2021-2022 | |
| Sirtex Medical INC | $58.61 | 2025 | Sir-Spheres Microspheres, Lava Les (Liquid Embolic System) |
| Angiodynamics, INC. | $55.69 | 2022 | |
| Gilead Sciences, INC. | $46.55 | 2021 | |
| Ethicon US, LLC | $44.17 | 2022-2023 | Certus 140 |
| Trisalus Life Sciences, INC. | $40.90 | 2024-2025 | Trinav Infusion System |
| Janssen Pharmaceuticals, INC | $36.72 | 2021-2024 | Xarelto |
| Teleflex LLC | $30.30 | 2023 | Turnpike |
| Merck Sharp & Dohme LLC | $28.12 | 2021-2025 | Zerbaxa |
| Melinta Therapeutics, LLC | $27.78 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $26.40 | 2021 | |
| Paratek Pharmaceuticals, INC. | $17.75 | 2025 | Nuzyra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.14 | 2021 | |
| Terumo Medical Corporation | $16.56 | 2024 | Azur Cx Detachable |
| Nestle Healthcare Nutrition INC. | $14.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Greshow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.